Navigation Links
Endologix Announces FDA Approval of AFX™ Endovascular AAA System
Date:6/15/2011

g technology.

John McDermott, President and Chief Executive Officer of Endologix, commented, "Achieving FDA approval for the AFX System is an important milestone for Endologix and for the physicians and patients we serve. The advances incorporated into the AFX System will give physicians even more confidence and precision in treating a wide range of AAA anatomies. The SVS annual meeting provides an ideal venue to begin educating physicians on the new system, which we expect to be commercially available within a couple of months following the necessary sales force training and inventory build."

In addition to AFX, the Company's complete product portfolio will be highlighted at the SVS Annual Meeting.  This includes the investigational Nellix® Endovascular System and the Ventana™ Fenestrated Stent Graft System, both of which will be featured in symposia at SVS.

About Endologix, Inc.Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at www.endologix.com.  

Forward-Looking Statements Except for historical information contained herein, this news release contains forward-looking statements, the accuracy of which are necessarily subject to risks and uncertainties, all of which are difficult or impossible to predict accurately and many of which are beyond the control of Endologix. Many factors may cause actual results to dif
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Endologix Comments on Alleged Patent Infringement
2. Endologix Responds to Alleged Patent Infringement
3. Endologix to Report Third Quarter 2009 Financial Results on October 27, 2009
4. Endologix Reports 47% Third Quarter 2009 Revenue Growth
5. Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement
6. Endologix Enters Development Agreement and Exclusive License for Balloon Expandable Stent Technology
7. Endologix Receives CE Mark Approval for Expanded Line of Powerlink Products and PowerFit Aortic Extensions
8. Endologix to Report Third Quarter 2010 Financial Results on October 27, 2010
9. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
10. Endologix to Present at Oppenheimer 21st Annual Healthcare Conference
11. Endologix Reports 30% Third Quarter 2010 Revenue Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 Medina Medical announced today that Mr. ... the Board of Directors on August 18, 2014. Mr. ... commercialization experience, including over a decade of direct experience ... a Partner of the medical device incubator The Foundry, ... Foundry start-ups. Mr. Engelson previously served as the Chief ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "China Orthopedic Instrument Industry Report, 2014-2017" report to ... population and rising proportion of reimbursement for medical expenses, ... released, with its scale presenting a CAGR of 19.2% ... are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... 29, 2014 According to ... by Extraction type (SFE, Cold Pressed, Organic Solvent, & ... Pharmaceutical, Food Supplements, Fragrance, & Others) - Global Trends ... and segments the Amaranth Seed Oil Market with ... in terms of value. The Amaranth Seed Oil ...
Breaking Medicine Technology:Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... Calif., July 26, 2011 Epitomics, Inc., a ... based on its groundbreaking Rabbit Monoclonal (RabMAb®) technology, ... novel cancer-related antibodies that were developed through a ... Cancer Research. The goal of this partnership is ...
... 26, 2011 Bacterin International Holdings, Inc. ... the development of revolutionary bone graft material and anti-infective coatings ... August 11, at 4:30 p.m. Eastern time to discuss results ... will be issued in a press release after the close ...
Cached Medicine Technology:Epitomics Releases New Antibodies Developed With the National Cancer Institute's Center for Cancer Research 2Bacterin Sets Second Quarter 2011 Conference Call for Thursday, August 11, 2011 at 4:30 p.m. ET 2
(Date:8/29/2014)... review website Top10BestSEOHosting.com compares many popular hosting suppliers and ... suppliers for webmasters for webmasters who want to buy ... at affordable prices. , GoDaddy offers three Linux ... plans depends on the length of a contract. This ... flexible hosting packages, decent uptime record and beneficial support ...
(Date:8/29/2014)... Cosmetic Town has devised a system ... its doctors. Cosmetic Town utilizes a validated referral ... in their field are chosen to present their procedure. ... direct link to potentially hundreds of recommended doctors in ... to communicate through the site’s community features and multimedia ...
(Date:8/29/2014)... a famous online supplier of trendy clothes, has unveiled its ... moment, all these mini outfits are offered at discounted rates, ... is September 14. , The company’s senior spokesman states, ... hot designs, we have listed some of the best-selling items ... ladies to get high quality, fashionable clothes. Many of our ...
(Date:8/29/2014)... Panic attacks are extremely difficult to ... intense stress and fear, which appears with no particular ... insecurity and affecting relationships. , A panic attack can ... symptoms that patients can deal with. Anxiety, shortness of ... panic attacks is extremely important for sufferers, who need ...
(Date:8/29/2014)... DailyGossip.org publishes a review to the Natural Multiple ... curing multiple sclerosis in a fast and natural way. ... M. Levin, who has become well known as a ... alternative remedies for a series of health problems when ... all cases for the cure of some disorders. ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town Now Advocates for the Rights of Cosmetic Patients Using Novel Approach 2Health News:Cheap Sexy Mini Dresses Added To The Product Line Of Skmen.com 2Health News:60 Second Panic Solution Review Exposes Simple Panic Attacks Remedy 2Health News:New Natural Multiple Sclerosis Treatment Review Reveals Gary M. Levin’s Unique Cure 2
... undergo heart surgery are more than three times as likely ... the next three months, a new study finds. ... during the most critical post-operative recovery period," says Ellen Idler, ... study, which appears in the March issue of the ...
... The Center for Public-Private Partnerships at The Henry M. ... is pleased to announce the recipients of the 2012 ... themselves through excellence and selfless dedication to advancing medicine ... veterans and their families. The recipients will be honored ...
... are vitamin D deficient and there is an inverse ... a recent study accepted for publication in The Endocrine ... (JCEM). Recommendations for dietary vitamin D intake in ... because vitamin D deficiency is extraordinarily prevalent in this ...
... D.C. People with schizophrenia report improved functioning ... according to results announced today from a six-month ... for People with Schizophrenia , was spearheaded by ... Council) and administered at 10 community behavioral health ...
... HealthDay Reporter , MONDAY, March 5 (HealthDay News) ... College of Physicians (ACP) put the emphasis on individual risk. ... get screened starting at age 50, whereas people at high ... or family history of the disease -- should get screened ...
... (HealthDay News) -- ,Hospitalizations from angiodema, a serious swelling ... the eyes and mouth, are on the rise, new ... searched a national database for hospitalizations due to allergic ... and angiodema. While hospitalization rates for the other ...
Cached Medicine News:Health News:Marriage: A powerful heart drug in short supply 2Health News:HJF Center announces Heroes of Military Medicine award recipients 2Health News:Vitamin D deficiency linked to higher mortality in female nursing home residents 2Health News:Pilot program demonstrates measureable benefits for people with schizophrenia 2Health News:New Colon Cancer Screening Guidelines Focus on Individual Risk 2Health News:New Colon Cancer Screening Guidelines Focus on Individual Risk 3
SkinStation, powered by LHE, is Radiancys flagship product. A powerhouse by design, it incorporates todays most sought after applications all on one user-friendly system ....
Inquire...
Sebia's Hb AFSC Control provides excellent resolution of normal hemoglobins A & F and abnormal hemoglobins S & C. The control is designed for use with Sebia's Hydragel Hemoglobin and Hydragel Acid He...
... Normal and Hypergamma Controls are ... either agarose gels or Sebia's ... Our unique control manufacturing process ... the other serum components, presenting ...
Medicine Products: